Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 17/20 | 0.46 |
| ▸ | ITGAV | P06756 | 4/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 15/20 | 0.44 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7032405 | 0.99 | ITGB3 (0.46) | ITGB3ITGAVITGA2BITGB5KAT6A | |
| SCHEMBL7037924 | 0.91 | ITGB3 (0.55) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL7037266 | 0.88 | ITGB3 (0.54) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL7036686 | 0.84 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| SCHEMBL7035444 | 0.84 | ITGB3 (0.64) | ITGB3ITGAVITGA2B | |
| Hydrochloric Acid SCHEMBL7036683 | 0.83 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| Hydrochloric Acid SCHEMBL7030628 | 0.83 | ITGB3 (0.43) | ITGB3ITGAVITGA2B | |
| SCHEMBL7032427 | 0.82 | ITGB3 (0.41) | ITGB3ITGAVITGA2B | |
| SCHEMBL7032444 | 0.79 | ITGB3 (0.55) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL7038923 | 0.78 | ITGB3 (0.40) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030186967-A1 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 2003-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186967-A1 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | ASGR1, TEK, APLNR | ITGB3 403/4885ITGAV 289/4885ITGA2B 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.